Leigh Maria Ramos Platt
Neurology with Special Qualifications in Child Neurology · Los Angeles, CANPI 1407935844
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,029 of the $59,357 with a category attached, or 67.4%. 6 manufacturers reported payments, led by Sarepta Therapeutics, Inc. at 56.3% of the total. Reporting peaked in 2024 at $38,765 and has fallen 81.2% since, to $7,304 in 2025. Among neurology with special qualifications in child neurology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $1099.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$33K
- Catalyst Pharmaceuticals, Inc.$12K
- Janssen Scientific Affairs, LLC$7K
- Biogen$4K
- Genentech, Inc.$1K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$1K
Across 83 payments — averaging $11,100 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sarepta Therapeutics, Inc.$483K
- PTC Therapeutics, Inc.$176K
- Novartis$98K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$61K
- Genentech, Inc.$51K
- NS Pharma, Inc.$24K
- plus $28K from 2 others
What the payments were for
- Consulting fees$40,02967%
- Speaking & faculty fees$12,11320%
- Travel & lodging$5,4199%
- Food & beverage$1,3172%
- Education$4791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 18 | $33,401 |
| Catalyst Pharmaceuticals, Inc. | 12 | $12,228 |
| Janssen Scientific Affairs, LLC | 7 | $7,304 |
| Biogen | 9 | $4,328 |
| Genentech, Inc. | 4 | $1,073 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 4 | $1,023 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Elevidys$13,046
- AGAMREE$11,982
- Exondys 51$2,400
- ZOLGENSMA$848
How this compares
$59,357 in reported general payments places this provider in the 90th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in Los Angeles
- Rajsekar RajaramanLos Angeles$134K
- Deborah HolderLos Angeles$130K
- Shaun HussainLos Angeles$40K
- Mohsen HamzaLos Angeles$24K
- Tena RosserLos Angeles$7K
- Arthur PartikianLos Angeles$7K
- Michael ChezSacramento$374K
- Allen BottOakland$372K
- Joseph SullivanSan Francisco$240K
- Ann SegerenStanford$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.